Blog
RSS FeedPosted by Michael Wonder on 15 Apr 2020
Science says Trump was right: malaria drugs need to be pursued as a coronavirus therapy
14 April 2020 - When President Donald Trump suggested that an off-labeled repurposing of a pair of old antimalarial drugs ...
Posted by Michael Wonder on 15 Apr 2020
Novo Nordisk offers free 90 day insulin supply to people experiencing financial hardship due to COVID-19
14 April 2020 - People with diabetes using Novo Nordisk insulin who have lost health insurance coverage because of a ...
Posted by Michael Wonder on 15 Apr 2020
FEMA ships out nearly 20 million hydroxychloroquine tablets
14 April 2020 - A spokesperson for the agency confirmed that it has sent out 19.1 million tablets, including to Pittsburgh, ...
Posted by Michael Wonder on 15 Apr 2020
FDA approves first therapy for treatment of low grade upper tract urothelial cancer
15 April 2020 - Today, the U.S. FDA approved Jelmyto (mitomycin gel), the first therapy to treat low-grade upper tract urothelial ...
Posted by Michael Wonder on 15 Apr 2020
Product specific guidances for chloroquine phosphate and hydroxychloroquine sulphate
13 April 2020 - The FDA plays a critical role in protecting the United States from threats including emerging infectious ...
Posted by Michael Wonder on 14 Apr 2020
LifeMax receives fast track designation for LM-030 for the treatment of Netherton syndrome
14 April 2020 - LifeMax Laboratories today announced that the FDA granted fast track designation to LM-030, an investigational therapy licensed ...
Posted by Michael Wonder on 14 Apr 2020
Drug evaluation during the COVID-19 pandemic
14 April 2020 - The search for a treatment for COVID-19 is testing our country’s ability to quickly develop, test, ...
Posted by Michael Wonder on 14 Apr 2020
Alnylam receives fast track designation for vutrisiran for the treatment of the polyneuropathy of hATTR amyloidosis
14 April 2020 - Alnylam Pharmaceuticals announced today that the U.S. FDA has granted fast track designation to vutrisiran, an ...
Posted by Michael Wonder on 14 Apr 2020
Vaccine development is a case of 'market failure'
13 April 2020 - Reliance on the private market to develop vaccines has failed, leaving us vulnerable to pandemics such as ...
Posted by Michael Wonder on 14 Apr 2020
Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review
13 April 2020 - The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 ...
Posted by Michael Wonder on 14 Apr 2020
Regulators split on anti-malarials for COVID-19
11 April 2020 - US and French authorities have authorised the use of chloroquine and hydroxychloroquine, but the EU regulator and ...
Posted by Michael Wonder on 14 Apr 2020
Potential coronavirus drugs may cost as little as $1, study says
10 April 2020 - Treatments being studied sell for hundreds of times their cost. ...
Posted by Michael Wonder on 14 Apr 2020
Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs
13 April 2020 - In July 2018, the FDA first published a table listing all surrogate measures that it has used, ...
Posted by Michael Wonder on 14 Apr 2020
COVID-19: world needs a global approach to fight: Bill Gates
12 April 2020 - Over the past few weeks, I’ve spoken to dozens of experts about COVID-19, and there’s clear ...
Posted by Michael Wonder on 13 Apr 2020
Fennec Pharmaceuticals announces FDA filing acceptance and priority review of new drug application for Pedmark
13 April 2020 - FDA grants priority review and sets a Prescription Drug User Fee Act target action date of 10 ...